AI assistant
Sending…
ImmunityBio, Inc. — Director's Dealing 2023
Jun 6, 2023
31529_dirs_2023-06-05_c07601e5-1497-4093-a485-6794a0c82f69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ImmunityBio, Inc. (IBRX)
CIK: 0001326110
Period of Report: 2023-06-02
Reporting Person: Brennan John Owen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-02 | Common Stock | P | 5000 | $2.74 | Acquired | 5000 | Direct |
| 2023-06-02 | Common Stock | P | 10000 | $2.80 | Acquired | 15000 | Direct |
| 2023-06-02 | Common Stock | P | 10000 | $2.90 | Acquired | 25000 | Direct |
More from ImmunityBio, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24